Filtered By:
Condition: Atrial Fibrillation
Countries: USA Health

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 257 results found since Jan 2013.

State-of-the-Art Review: Evidence on Red Meat Consumption and Hypertension Outcomes
Am J Hypertens. 2022 May 13:hpac064. doi: 10.1093/ajh/hpac064. Online ahead of print.ABSTRACTHypertension (HTN) is a well-established risk factor for cardiovascular diseases (CVD), including ischemic heart disease, stroke, heart failure and atrial fibrillation. The prevalence of HTN, as well as mortality rates attributable to HTN, continue to increase, particularly in the United States and among Black populations. The risk of HTN involves a complex interaction of genetics and modifiable risk factors, including dietary patterns. In this regard, there is accumulating evidence that links dietary intake of red meat with a high...
Source: American Journal of Hypertension - May 13, 2022 Category: Cardiology Authors: Tara Shrout Allen Harpreet S Bhatia Alexis C Wood Shabnam R Momin Matthew A Allison Source Type: research

Left atrial appendage closure using WATCHMAN device in chronic kidney disease and end stage renal disease patients
ConclusionPatients with and without ESRD/CKD who undergo LAA occlusion with Watchman have similar procedure related, in-hospital mortality and complications.This article is protected by copyright. All rights reserved
Source: Pacing and Clinical Electrophysiology : PACE - May 28, 2022 Category: Cardiology Authors: Shakeel Jamal, Mohsin Sheraz Mughal, Asim Kichloo, Ehizogie Edigin, Muhammad Zia Khan, Abdul Mannan Khan Minhas, Muzaffar Ali, Khalil Kanjwal Tags: DEVICES Source Type: research

Left atrial appendage closure using WATCHMAN device in chronic kidney disease and end ‐stage renal disease patients
ConclusionPatients with and without ESRD/CKD who undergo LAA occlusion with Watchman have similar procedure related, in-hospital mortality, and complications.
Source: Pacing and Clinical Electrophysiology : PACE - June 9, 2022 Category: Cardiology Authors: Shakeel Jamal, Mohsin Sheraz Mughal, Asim Kichloo, Ehizogie Edigin, Muhammad Zia Khan, Abdul Mannan Khan Minhas, Muzaffar Ali, Khalil Kanjwal Tags: DEVICES (DIRECT VIA EEO) Source Type: research

Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial
CONCLUSION: Catheter ablation of atrial fibrillation was economically attractive compared with drug therapy in the CABANA Trial overall at present benchmarks for health care value in the United States on the basis of projected incremental QALYs but not LYs alone.PMID:35726631 | DOI:10.1161/CIRCULATIONAHA.122.058575
Source: Circulation - June 21, 2022 Category: Cardiology Authors: Derek S Chew Yanhong Li Patricia A Cowper Kevin J Anstrom Jonathan P Piccini Jeanne E Poole Melanie R Daniels Kristi H Monahan Linda Davidson-Ray Tristram D Bahnson Hussein R Al-Khalidi Kerry L Lee Douglas L Packer Daniel B Mark CABANA Investigators Source Type: research

Comparison of Dabigatran Versus Warfarin Treatment for the Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation
Atrial fibrillation is one of the most common arrhythmias in the United States and is associated with an increased risk of thromboembolic events.1 The American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines recommend oral anticoagulation with either warfarin or oral non-vitamin K antagonists for patients diagnosed with atrial fibrillation with a high risk for ischemic stroke based on the CHA2DS2-VASc score.2 The recently published article “Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation” discussed the efficacy of...
Source: The American Journal of Cardiology - October 7, 2022 Category: Cardiology Authors: Marwa S.H. Abrahim, Olufemi Sofola-James, Zeina Bani Hani Source Type: research

High rates of oral anticoagulation in atrial fibrillation patients observed in a large multi-specialty health system in the Northeast
ConclusionsWe show dramatically increased OAC usage among patients with AF and that NOACs comprise the large majority of OACs compared with previous studies. This suggests an association between widespread adoption of NOACs and increased oral anticoagulation rates. Future directions include assessing barriers to oral anticoagulation and developing interventions to reduce disparity in OAC use between clinics.
Source: Journal of Interventional Cardiac Electrophysiology - October 20, 2022 Category: Cardiology Source Type: research

Andexanet Alfa and its Clinical Application
Heart Int. 2020 Jun 19;14(1):20-23. doi: 10.17925/HI.2020.14.1.20. eCollection 2020.ABSTRACTFactor Xa (FXa) inhibitors are widely used for stroke prevention in patients with nonvalvular atrial fibrillation, and for the treatment and prevention of deep venous thrombosis and pulmonary embolism. Compared with warfarin, individual FXa inhibitors are associated with a lower risk of major bleeding. Nevertheless, bleeding remains a feared complication of any anticoagulant therapy. Despite their demonstrated safety, implementation of FXa inhibitors in clinical practice may have been limited by the lack of a specific antidote. Rece...
Source: Heart International - October 24, 2022 Category: Cardiology Authors: Fauve A Noordergraaf Marco Alings Source Type: research